» Authors » Sebastien Champion

Sebastien Champion

Explore the profile of Sebastien Champion including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 50
Citations 156
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Volle K, Merdji H, Bataille V, Lamblin N, Roubille F, Levy B, et al.
Clin Res Cardiol . 2024 Oct; PMID: 39441346
Background: Despite scarce data, invasive mechanical ventilation (MV) is widely suggested as first-line ventilatory support in cardiogenic shock (CS) patients. We assessed the real-life use of different ventilation strategies in...
2.
Manzo-Silberman S, Martin A, Boissier F, Hauw-Berlemont C, Aissaoui N, Lamblin N, et al.
J Crit Care . 2024 Mar; 82:154785. PMID: 38493531
Background: Cardiogenic shock (CS) is the most severe form of acute heart failure. Discrepancies have been reported between sexes regarding delays, pathways and invasive strategies in CS complicating acute myocardial...
3.
Matsushita K, Delmas C, Marchandot B, Roubille F, Lamblin N, Leurent G, et al.
J Am Heart Assoc . 2024 Feb; 13(5):e030975. PMID: 38390813
Background: The effects of pharmacological therapy on cardiogenic shock (CS) survivors have not been extensively studied. Thus, this study investigated the association between guideline-directed heart failure (HF) medical therapy (GDMT)...
4.
Cherbi M, Bonnefoy E, Lamblin N, Gerbaud E, Bonello L, Roubille F, et al.
Front Cardiovasc Med . 2023 Sep; 10:1167738. PMID: 37731529
Background: Cardiogenic shock (CS) is the most severe form of heart failure (HF), resulting in high early and long-term mortality. Characteristics of CS secondary to supraventricular tachycardia (SVT) are poorly...
5.
Karsenty C, Touafchia A, Ladouceur M, Roubille F, Bonnefoy E, Bonello L, et al.
Arch Cardiovasc Dis . 2023 Aug; 116(8-9):390-396. PMID: 37598062
Background: Data on cardiogenic shock in adults with congenital heart disease (ACHD) are scarce. Aim: We sought to describe cardiogenic shock in ACHD patients in a nationwide cardiogenic shock registry....
6.
Merdji H, Gantzer J, Bonello L, Lamblin N, Roubille F, Levy B, et al.
Eur Heart J Acute Cardiovasc Care . 2023 Jul; 12(10):682-692. PMID: 37410588
Aims: Characteristics, management, and outcomes of patients with active cancer admitted for cardiogenic shock remain largely unknown. This study aimed to address this issue and identify the determinants of 30-day...
7.
Cherbi M, Roubille F, Lamblin N, Bonello L, Leurent G, Levy B, et al.
Front Cardiovasc Med . 2023 Feb; 10:1092904. PMID: 36776263
Background: Cardiogenic shock (CS) is a life-threatening condition carrying poor prognosis, potentially triggered by ventricular arrhythmia (VA). Whether the occurrence of VA as trigger of CS worsens the prognosis compared...
8.
Delmas C, Roubille F, Lamblin N, Bonello L, Leurent G, Levy B, et al.
ESC Heart Fail . 2022 Jan; 9(1):408-419. PMID: 34973047
Aims: Published data on cardiogenic shock (CS) are scarce and are mostly focused on small registries of selected populations. The aim of this study was to examine the current CS...
9.
Leopold V, Gayat E, Pirracchio R, Spinar J, Parenica J, Tarvasmaki T, et al.
Intensive Care Med . 2018 Sep; 44(11):2022-2023. PMID: 30215188
Because of a technical error, the code corresponding to the outcome for the Basir et al. cohort was mis-implemented in the original version of our article. Characteristics of the cohort...
10.
Leopold V, Gayat E, Pirracchio R, Spinar J, Parenica J, Tarvasmaki T, et al.
Intensive Care Med . 2018 Jun; 44(6):847-856. PMID: 29858926
Objective: Catecholamines have been the mainstay of pharmacological treatment of cardiogenic shock (CS). Recently, use of epinephrine has been associated with detrimental outcomes. In the present study we aimed to...